FDD Conclave 2021 Login Now Register Now

16 - 17 December, 2021 | 2:00pm - 6:00pm


Time Session
2:00pm – 2:10pm Welcome Address by Express Pharma
Speaker : Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare
2:10pm – 2:25pm Special Address :
Topic : In Pursuit of Excellence
Speaker : Ravi Udaya Bhaskar, Director-General, Pharmexcil
2:25pm – 2:45pm Topic : Documented Solutions - How customers benefit from Ideal Cures
Speaker : Suresh Pareek, MD, Ideal Cures
2:45pm – 3:05pm Topic : Application of Quality By Design in Development of NovaPure® Closures
Speaker : Prabhaharan Sankaran, Technical Account Specialist, West Pharmaceutical Services, India
3:05pm – 4:05pm Panel Discussion :
Topic : The Pandemic effect on FDD
Sub-Topics :
- Emerging practices and trends in FDD, post-COVID-19
- Innovations in excipients, ingredients
- Optimisation of drug formulation design
- Lessons in targeted drug delivery from the pandemic
- Role of automation and AI in FDD
- Smart drug delivery systems
- Accelerating vaccine formulation development
Panelists :
Dr Alagumurugan Alagarswamy, VP & Head-R&D, Maiva Pharma (Moderator)
Dr Rakesh Kumar Bhasin, VP & Head R&D (Formulations), Biocon Pharma
Dr Sumedha Nadkar, Site Head & Sr Director, Perrigo India Laboratories
Dr Pirthi Pal Singh, VP & Head - R&D, Tirupati Group
4:05pm – 4:35pm Topic : Two high-resolution measuring systems for Research & Development and Quality Control
Speaker : Uwe Killeman, Field Marketing Manager - Particle Counting & Characterization - Europe, Beckman Coulter Life Sciences
4:35pm – 4:55pm Topic : Automation and AI for Formulations Development
Speaker : Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser - Geneva
4:55pm – 6:00pm Panel Discussion :
Topic : Optimising FR&D to expedite regulatory compliance
Sub-Topics :
- Upcoming pharma regulations in different markets (US, EU, emerging markets)
- Impact of processing and manufacturing tech advancements on FDD
- FDD strategies to meet upcoming regulations
- Reformulating existing drugs with fewer side effects
Panelists :
Vinod Arora, Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI) (Moderator)
Dr Sajeev Chandran, Director, Adv. Drug Delivery Research & IVIVC/ Biopharmaceutics , Pharma R&D, Lupin
Dr Sukhjeet Singh, Chief Scientific Officer, Sentiss Pharma
Dr C Muthulingam, VP-Formulations, Mankind Pharma
Ravikumar N, Sr VP, MSN Laboratories

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus).

Copyright © The Indian Express [P] Ltd. All Rights Reserved.